Evaluation of a new porous titanium hip implant
Official title: Prospective, Multicentre, Non-randomised, Open Study Evaluating the Efficacy and Fixation of the Mpact 3D Metal Monolit Cup
Run by Medacta International SA · NCT06748885 · Data updated 2026-11-12
This study is testing a new hip implant made of porous titanium to see if it helps patients recover better and move more easily after hip surgery.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years to 75 Years |
| Sex | All |
| Enrollment | 88 (estimated) |
| Sponsor | Medacta International SA Industry-sponsored |
| Locations | 3 sites (Nantes and 2 other locations) |
| Status | Recruiting |
| Started | February 28, 2024 |
| Main results expected | December 2030 |
| Study ends | December 2030 |
| Registry record updated | October 8, 2026 |
| Trial ID | NCT06748885 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are patients aged 18 to 75 who are eligible for primary total hip arthroplasty and covered by the French Social Security system.
✕Probably not a fit
Patients with inflammatory arthritis, previous hip surgeries, or severe comorbidities may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study focuses on the Mpact 3D Metal Monolith cup, a new implant designed for total hip arthroplasty (THA). The study aims to assess the implant's performance in terms of osseointegration, joint stability, and range of motion. By utilizing a porous titanium coating, the implant promotes bone growth and provides enhanced primary stability. The study will involve patients eligible for primary THA and will gather data on their outcomes post-surgery.
Why it matters
Potential benefit: If successful, this study could lead to improved outcomes and quality of life for patients undergoing total hip arthroplasty.
How similar studies have gone: While this approach is innovative, similar studies have shown promise in improving hip implant technology and outcomes.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Patient with a disease that corresponds to the indications for use of Medacta implants (according to the instructions for use) 2. Patient eligible for primary total hip arthroplasty 3. Patient aged between 18 and 75 years 4. Patient covered by the French Social Security system or an equivalent protection scheme. 5. Patient able, in the investigator's opinion, to comply with the requirements of the study. Exclusion Criteria: 1. Patient suffering from inflammatory arthritis 2. Previously operated hip 3. Patient requiring a transplant 4. Hip tumour involved 5. Patient with progressive local or systemic infection 6. Severe acetabular dysplasia 7. Patient with muscle loss, neuromuscular disease or vascular impairment of the affected limb. 4\. Patient with known medical problems that may compromise independent recovery of mobility 5. Patient with a BMI greater than 40 kg/m². 6. Patient with major cognitive impairment that prevents him/her from fully understanding the requirements of the study 7. Patient living in a geographical area where study follow-up is not possible. 8. Patient taking part in interventional research 9. Minor patient 10. Protected adult patient 11. Vulnerable person according to article L1121-6 of the Public Health Code
Where it's running
-
Hôpital Cochin
Paris, France Recruiting -
Clinique Brétéché
Nantes, France Not yet recruiting -
Hôpital Lariboisière
Paris, France Not yet recruiting
Study contacts
- Study coordinator: Philippe Anract
- Email: philippe.anract@aphp.fr
- Phone: 01 58 41 30 38
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Suzetrigine for pain control after primary total hip replacement
This will test whether taking Suzetrigine before surgery and for seven days afterward reduces opioid use and improves pain control in adults having a primary total hip replacement.
-
Choose to Move Replacement Ready for OA patients waiting for hip or knee replacement
This program tests a tailored, online version of a 3-month activity and social-connection plan for older adults with hip or knee osteoarthritis who are waiting for joint replacement surgery to see if it improves physical activity and health while they wait.
-
Foot core exercises after total hip replacement
This trial tests whether adding foot core exercises to the usual hip rehab helps improve foot and leg strength, balance, and foot structure in people who recently had a hip replacement.
-
Dressing Type and Change Frequency for Healing Wounds After Hip Replacement
This study tests whether a VACUTEX capillary-action dressing or standard dressings with different change intervals help wounds heal faster after a primary total hip arthroplasty in adults 65 and older.
-
Tipmed™ Primary Hip Prosthesis: 24-Month Post-Market Follow-Up in Adults
This PMCF study tests the safety and 24‑month performance of the Tipmed hip prosthesis in adults undergoing primary hip replacement.
-
Post-op prednisone vs standard steroid regimen after knee or hip replacement
This study tests a 5-day oral prednisone course after knee or hip replacement to see if pain, swelling, and glucose control are better or different than the usual intraoperative steroid approach.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.